Guangdong Marubi Biotechnology Co., Ltd.

SHSE:603983 Stok Raporu

Piyasa değeri: CN¥12.0b

Guangdong Marubi Biotechnology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Guangdong Marubi Biotechnology has a total shareholder equity of CN¥3.4B and total debt of CN¥250.9M, which brings its debt-to-equity ratio to 7.3%. Its total assets and total liabilities are CN¥4.4B and CN¥991.3M respectively. Guangdong Marubi Biotechnology's EBIT is CN¥264.8M making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥2.1B.

Anahtar bilgiler

7.3%

Borç/özkaynak oranı

CN¥250.91m

Borç

Faiz karşılama oranı-4.6x
NakitCN¥2.10b
EşitlikCN¥3.44b
Toplam yükümlülüklerCN¥991.30m
Toplam varlıklarCN¥4.44b

Son finansal sağlık güncellemeleri

Recent updates

Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Sep 26
Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Aug 30
Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Jun 19
Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

May 29
Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

May 07
Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Mar 27
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

Feb 29
Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 603983's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥969.6M).

Uzun Vadeli Yükümlülükler: 603983's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥21.7M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 603983 has more cash than its total debt.

Borcun Azaltılması: 603983's debt to equity ratio has increased from 0% to 7.3% over the past 5 years.

Borç Kapsamı: 603983's debt is well covered by operating cash flow (134.9%).

Faiz Kapsamı: 603983 earns more interest than it pays, so coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin